PRESENTED BY: SRI RAMYA.

INTRODUCTION
FUNDAMENTALANALYSIS: Its a method of evaluating a security that entails attempting to measure its intrinsic

value by examining related economic, financial and other qualitative and quantitative factors. IT INCLUDES:. Fundamental analysis is an attempt to study everything that can affect the securities value, including macroeconomic factors (like the over all economy and industry conditions) and company-specific factors(like financial condition and management).

OBJECTIVES:  To analyze the performance of stocks fundamentally from past six months.  To evaluate the scope of investing in that particular stock with respect to an investor. To find out the factors that had effected for major fluctuation in the stock. To forecast the performance of that particular stock for forth coming three months SCOPE OF THE STUDY:  This study helps to know about the performance of the selected stocks in depth.  It gives a clear idea of both the factors that are of macro level and of company level effecting the stock performance. DATA SOURCE: This entire data is from secondary source.

SAMPLE DESIGN: I have taken the following stocks from the equity market . BHEL(Bharat Heavy electrical limited) . Mahindra Satyam Dr Reddys Labs

LIMITATIONS:  There is no any scope of getting primary data because the entire data that is

been collected is from secondary source .  The data that is obtained gives the analysis for only past one year and so the result may not apply in the long run.

The data that is given by the company through its website is limited.

3000

2500

2000

1500

bhel reddys satyam

1000

500

FINDINGS: BHEL  key drivers for its growth are acceleration capex.  recent success in super critical boiler had helped it in its growth of 22% in net profit of 1st quarter fy12.  It is having a good operating leverage and good order book to sales ratio.  At present it is not desirable for the investors to invest in this stock.  Mahindra Satyam:  Return to growth  incremental business 18-20% margins.  The investor can see to invest in this stock in long run. Dr.Reddys: It is estimated that there will be a substantial growth for this, because there going to be a boom in the health sector and so investing in this stock leads to good returns. core earnings of FY12-13 estimate is down graded by 7.8%  1QFY12 revenue increased by 17.5%, EBIT increased by 12.3%,ebit margin at 13.8% was down 70bps.  pat increased 37% to 2.9 bn aided mainly by a low tax rate.